VAPB is a negative regulator of STING-mediated innate immune signaling
Science Advances · 2025
DOI: 10.1126/sciadv.aea3996 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Wangsheng Ji und 8 weiteren Autor:innen. Beteiligte Einrichtung: Joint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng 475000, China. Hauptthemen laut MEDLINE: Membrane Proteins, Immunity, Innate, Signal Transduction, Vesicular Transport Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Tianjin City, the Fellowship of China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Stimulator of IFN genes (STING) is an endoplasmic reticulum (ER) signaling receptor involved in the type I interferon response to pathogen- or self-derived cytosolic double-stranded DNA. Excessive activation of STING is associated with many diseases, but the regulatory mechanism of STING activation remains to be further elucidated. Here, we identify VAPB as a negative regulator of STING-mediated innate immune response. VAPB deficiency increases the expression of type I interferons under resting conditions or upon stimulation. Mechanistically, VAPB associates and translocates with STING, thereby regulating STING translocation, oligomerization, and recruitment of TBK1. In vivo, deficiency of VAPB enhances the expression of type I interferons and prevents lethality following HSV-1 infection. Furthermore, VAPB P56S, a pathogenic mutation causing amyotrophic lateral sclerosis (ALS), can promote STING-mediated innate immune response under resting conditions, which might contribute to further understanding of the relationship between cGAS-STING pathway and ALS. Our study identifies VAPB as a critical regulating factor in cGAS-STING–mediated innate immune responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Joint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng 475000, China.
- State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Protein Science, Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin 300071, China.
- Department of Biophysics, Johns Hopkins University, Baltimore, MD, USA.
ORCID-Profile: Wangsheng Ji, Yin Zhang, Lianfei Zhang, Qingqing Liu, Shengbo Niu, Yuqun Feng, Feilong Chen, Xinqi Liu, Xia Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Tianjin City
- the Fellowship of China Postdoctoral Science Foundation
Zitieren
APA
Ji, W., Zhang, Y., Zhang, L., Liu, Q., Niu, S., Feng, Y., Chen, F., Liu, X., & Li, X. (2025). VAPB is a negative regulator of STING-mediated innate immune signaling. Science Advances. https://doi.org/10.1126/sciadv.aea3996
Vancouver
Ji W, Zhang Y, Zhang L, Liu Q, Niu S, Feng Y, et al. VAPB is a negative regulator of STING-mediated innate immune signaling. Science Advances. 2025. doi:10.1126/sciadv.aea3996
BibTeX
@article{Ji2025,
author = {Ji, Wangsheng and Zhang, Yin and Zhang, Lianfei and Liu, Qingqing and Niu, Shengbo and Feng, Yuqun and Chen, Feilong and Liu, Xinqi and Li, Xia},
title = {VAPB is a negative regulator of STING-mediated innate immune signaling},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.aea3996}
}
EUVIMED